In the healthcare space, it is somewhat rare to find a true growth company. Most of the growth companies that people talk about in the industry are really medical device companies or drug companies. AmSurg (NASDAQ:AMSG) is definitely an exception to this rule though. The company is involved in acquiring and developing ambulatory surgery centers in partnership with physicians groups around the country. Trading at roughly 19X trailing EPS (and ~16.5X CY 2014 expected EPS), AMSG definitely is not cheap. That said, this premium valuation is more than fully justified by the company's roughly 14% average annual sales growth rate and 10% average annual net income growth rate over the last decade. AMSG has been remarkably consistent on...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|